Influence of SARS-CoV-2 Virus Infection on the Course of Psoriasis during Treatment with Biological Drugs.

Magdalena Mroz, Szymon Mućka, Martyna Miodońska, Dominika Ziolkowska, Ewa Hadas, Andrzej Bożek

Open access · goldAbstract readObservational Study

In one paragraph

Observational study in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

0.2field-weighted citation impact, top 49% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

Burden of immune-related skin diseases worldwide, 1991-2021: insights and prediction from the Global Burden of Disease Study.Frontiers in immunology · 2025
Article
Types of Psoriasis and Their Effects on the Immune System.Cureus · 2022
Review
Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.Journal of clinical medicine · 2021
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Magdalena MrozClinical Department of Internal Disease, Dermatology and Allergology, Medical University of Silesia, 40-055 Katowice, Poland.

Szymon MućkaClinical Department of Internal Disease, Dermatology and Allergology, Medical University of Silesia, 40-055 Katowice, Poland.

Martyna MiodońskaClinical Department of Internal Disease, Dermatology and Allergology, Medical University of Silesia, 40-055 Katowice, Poland.

Dominika ZiolkowskaClinical Department of Internal Disease, Dermatology and Allergology, Medical University of Silesia, 40-055 Katowice, Poland.

Ewa HadasClinical Department of Internal Disease, Dermatology and Allergology, Medical University of Silesia, 40-055 Katowice, Poland.

Andrzej BożekClinical Department of Internal Disease, Dermatology and Allergology, Medical University of Silesia, 40-055 Katowice, Poland.ORCID 0000-0003-2263-2263

Medical University of Silesia · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological ProductsCOVID-19PsoriasisHumansPandemicsSARS-CoV-2Biological Productsbiological drugsCOVID-19psoriasispsoriatic arthritis

Identifiers

PMID34577804

DOI10.3390/medicina57090881

PMCPMC8470849

OpenAlexW3196274206

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.